Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 416

1.

High-dose rate brachytherapy for Stage I/II papillary serous or clear cell endometrial cancer.

DuBeshter B, Estler K, Altobelli K, McDonald S, Glantz C, Angel C.

Gynecol Oncol. 2004 Aug;94(2):383-6.

PMID:
15297176
2.

Improved outcome at 10 years for serous-papillary/clear cell or high-risk endometrial cancer patients treated by adjuvant high-dose whole abdomino-pelvic irradiation.

Martinez AA, Weiner S, Podratz K, Armin AR, Stromberg JS, Stanhope R, Sherman A, Schray M, Brabbins DA.

Gynecol Oncol. 2003 Sep;90(3):537-46.

PMID:
13678721
3.

Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy.

Turner BC, Knisely JP, Kacinski BM, Haffty BG, Gumbs AA, Roberts KB, Frank AH, Peschel RE, Rutherford TJ, Edraki B, Kohorn EI, Chambers SK, Schwartz PE, Wilson LD.

Int J Radiat Oncol Biol Phys. 1998 Jan 1;40(1):77-84.

PMID:
9422561
4.

Ten-year outcome including patterns of failure and toxicity for adjuvant whole abdominopelvic irradiation in high-risk and poor histologic feature patients with endometrial carcinoma.

Stewart KD, Martinez AA, Weiner S, Podratz K, Stromberg JS, Schray M, Mitchell C, Sherman A, Chen P, Brabbins DA.

Int J Radiat Oncol Biol Phys. 2002 Oct 1;54(2):527-35.

PMID:
12243832
5.

The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.

Jolly S, Vargas CE, Kumar T, Weiner SA, Brabbins DS, Chen PY, Floyd W, Martinez AA.

Gynecol Oncol. 2006 Oct;103(1):87-93. Epub 2006 Mar 20.

PMID:
16545441
6.

Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy.

Murphy KT, Rotmensch J, Yamada SD, Mundt AJ.

Int J Radiat Oncol Biol Phys. 2003 Apr 1;55(5):1272-6. Review.

PMID:
12654437
7.

Vaginal brachytherapy for early stage uterine papillary serous and clear cell endometrial cancer.

Townamchai K, Berkowitz R, Bhagwat M, Damato AL, Friesen S, Lee LJ, Matulonis U, O'Farrell D, Viswanathan AN.

Gynecol Oncol. 2013 Apr;129(1):18-21. doi: 10.1016/j.ygyno.2012.12.026. Epub 2012 Dec 21.

PMID:
23262378
8.

Adjuvant high dose rate vaginal brachytherapy as treatment of stage I and II endometrial carcinoma.

Horowitz NS, Peters WA 3rd, Smith MR, Drescher CW, Atwood M, Mate TP.

Obstet Gynecol. 2002 Feb;99(2):235-40.

PMID:
11814503
9.

The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.

Cirisano FD Jr, Robboy SJ, Dodge RK, Bentley RC, Krigman HR, Synan IS, Soper JT, Clarke-Pearson DL.

Gynecol Oncol. 2000 Apr;77(1):55-65.

PMID:
10739691
10.

Outcome and pattern of failure in pathologic stage I-II papillary serous carcinoma of the endometrium: implications for adjuvant radiation therapy.

Mehta N, Yamada SD, Rotmensch J, Mundt AJ.

Int J Radiat Oncol Biol Phys. 2003 Nov 15;57(4):1004-9.

PMID:
14575831
11.

The role of vaginal brachytherapy in the treatment of surgical stage I papillary serous or clear cell endometrial cancer.

Barney BM, Petersen IA, Mariani A, Dowdy SC, Bakkum-Gamez JN, Haddock MG.

Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):109-15. doi: 10.1016/j.ijrobp.2012.03.011. Epub 2012 Apr 28.

PMID:
22543202
12.

Surgery and postoperative radiation therapy in FIGO Stage IIIC endometrial carcinoma.

Mundt AJ, Murphy KT, Rotmensch J, Waggoner SE, Yamada SD, Connell PP.

Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1154-60.

PMID:
11483324
13.

Pathologic stage I-II endometrial carcinoma in the elderly: radiotherapy indications and outcome.

Citron JR, Sutton H, Yamada SD, Mehta N, Mundt AJ.

Int J Radiat Oncol Biol Phys. 2004 Aug 1;59(5):1432-8.

PMID:
15275729
14.

Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO Grade 3 cancer?

Alektiar KM, McKee A, Lin O, Venkatraman E, Zelefsky MJ, McKee B, Hoskins WJ, Barakat RR.

Int J Radiat Oncol Biol Phys. 2002 Sep 1;54(1):79-85.

PMID:
12182977
15.

Intravaginal 1-week high-dose-rate brachytherapy alone for Stages I-II endometrial cancer.

Martínez-Monge R, Nagore G, Cambeiro M, Garrán C, Villafranca E, Jurado M.

Brachytherapy. 2007 Jul-Sep;6(3):195-200.

PMID:
17681240
16.

Vaginal brachytherapy alone is sufficient adjuvant treatment of surgical stage I endometrial cancer.

Solhjem MC, Petersen IA, Haddock MG.

Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1379-84. Review.

PMID:
16029796
17.

Intravaginal high-dose-rate brachytherapy for Stage IB (FIGO Grade 1, 2) endometrial cancer.

Alektiar KM, McKee A, Venkatraman E, McKee B, Zelefsky MJ, Mychalczak BR, Hoskins WJ, Barakat RR.

Int J Radiat Oncol Biol Phys. 2002 Jul 1;53(3):707-13.

PMID:
12062616
18.

Is adjuvant therapy necessary for stage IA and IB uterine papillary serous carcinoma and clear cell carcinoma after surgical staging?

Kwon JS, Abrams J, Sugimoto A, Carey MS.

Int J Gynecol Cancer. 2008 Jul-Aug;18(4):820-4. Epub 2007 Sep 24.

PMID:
17892450
19.

Improved outcome in patients treated with postoperative radiation therapy for pathologic stage I/II endometrial cancer.

Algan O, Tabesh T, Hanlon A, Hogan WM, Boente M, Lanciano RM.

Int J Radiat Oncol Biol Phys. 1996 Jul 15;35(5):925-33.

PMID:
8751401
20.

Adjuvant whole abdominal irradiation in clinical stages I and II papillary serous or clear cell carcinoma of the endometrium: a phase II study of the Gynecologic Oncology Group.

Sutton G, Axelrod JH, Bundy BN, Roy T, Homesley H, Lee RB, Gehrig PA, Zaino R.

Gynecol Oncol. 2006 Feb;100(2):349-54. Epub 2005 Oct 5.

PMID:
16213007

Supplemental Content

Support Center